Shenzhen Camsense Stabilization Period Ends Without Open-Market Trades

By Public Technologies
  • Shenzhen Camsense Technologies’ stabilization period for its global offering ended on October 25, 2026.
  • Overall coordinators fully exercised the over-allotment option for 1,738,300 H Shares, representing 15% of the initial offering, at HK$ 58.85 each.
  • The share issuance will generate approximately HK$ 98.7 million in additional net proceeds.
  • Stabilizing manager China International Capital Corporation Hong Kong Securities made no market purchases or sales of H Shares for price stabilization.
  • Trading in the over-allotment option shares is expected to begin on October 28, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shenzhen Camsense Technologies Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261025-12382337), on October 25, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.